<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03100656</url>
  </required_header>
  <id_info>
    <org_study_id>R01MH106781</org_study_id>
    <nct_id>NCT03100656</nct_id>
  </id_info>
  <brief_title>Study of Food Aversion in Patients With Anorexia Nervosa</brief_title>
  <official_title>Solving EPHX2 and Polyunsaturated Fatty Acid Interactions in Anorexia Nervosa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Toronto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study uses a meal-challenge protocol to assess if patients with anorexia nervosa show a
      differential meal-induced metabolism and response compared to healthy controls, and
      determines how genetic variation influence this difference.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Anorexia nervosa is a brain-based disorder that often leads to serious health consequences
      including death. The EPHX2 gene has been identified as a susceptibility gene for anorexia
      nervosa. With the application of complementary research approaches, this study aims to
      develop a multi-omics biomarker system for anorexia nervosa through a food-challenge
      protocol. The data will allow us to understand how disease susceptibility gene(s) contribute
      to food aversion, psychopathology, and outcome in patients with anorexia nervosa.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 10, 2016</start_date>
  <completion_date type="Anticipated">March 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of metabolism biomarker</measure>
    <time_frame>2 hours</time_frame>
    <description>Percentage change of metabolism marker</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Food aversion/anxiety</measure>
    <time_frame>2 hours</time_frame>
    <description>Percentage change of food aversion/anxiety score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>6 and 12 months</time_frame>
    <description>Change in body weight, kg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychopathology</measure>
    <time_frame>6 and 12 months</time_frame>
    <description>Percentage change in eating disorder psychopathology score</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Anorexia Nervosa</condition>
  <arm_group>
    <arm_group_label>All subjects</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All subjects will undergo the same food challenge protocol</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>A meat-based breakfast sandwich</intervention_name>
    <description>A meat-based breakfast sandwich</description>
    <arm_group_label>All subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ill AN subjects will meet current Diagnostic and Statistical Manual of Mental
             Disorders (DSM V) diagnosis of restricting-type AN, body mass index (BMI) between11
             kg/m2 and 17.5 kg/m2 .

          -  Recovered AN must meet the following criteria at time of study entry: 1) Past DSM V
             diagnosis of AN; 2) BMI between 18.5 kg/m2 and 30 kg/m2; 3) Having maintained a BMI of
             &gt;18.5 for at least one year.

          -  Control must be healthy adolescent or woman negative on our screen for AN, other Axis
             I psychiatric illnesses, and having maintained a BMI of between18.5-30 since the age
             of 18.

        Exclusion Criteria:

          -  Exclusion criteria for AN and control subjects includes: Organic brain syndrome,
             schizophrenia and schizoaffective disorder, untreated thyroid disease, renal disease,
             hepatic disease, and the use of fish-oil containing supplements within the last three
             months of the study. All pregnant and lactating individuals will be excluded.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pei-an (Betty) Shih, MPM, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Diego</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eileen Lam</last_name>
    <phone>416-603-5800</phone>
    <phone_ext>5494</phone_ext>
    <email>Eileen.Lam@uhn.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>D. Blake Woodside, MD FRCPC</last_name>
    <phone>416-340-4445</phone>
    <email>b.woodside@utoronto.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Program for Eating Disorders, Toronto General Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eileen Lam</last_name>
      <phone>416-603-5800</phone>
      <phone_ext>5494</phone_ext>
      <email>eileen.lam@uhn.ca</email>
    </contact>
    <contact_backup>
      <last_name>D. Blake Woodside, MD FRCPC</last_name>
      <phone>416-340-4445</phone>
      <email>b.woodside@utoronto.ca</email>
    </contact_backup>
    <investigator>
      <last_name>D. Blake Woodside, MD FRCPC</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pei-an (Betty) Shih, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://www.uhn.ca/MCC/PatientsFamilies/Clinics_Tests/Eating_Disorder/Pages/our_team.aspx</url>
    <description>Program for Eating Disorders, Toronto General Hospital</description>
  </link>
  <reference>
    <citation>Shih PB. Integrating multi-omics biomarkers and postprandial metabolism to develop personalized treatment for anorexia nervosa. Prostaglandins Other Lipid Mediat. 2017 Sep;132:69-76. doi: 10.1016/j.prostaglandins.2017.02.002. Epub 2017 Feb 21.</citation>
    <PMID>28232135</PMID>
  </reference>
  <reference>
    <citation>Shih PA, Woodside DB. Contemporary views on the genetics of anorexia nervosa. Eur Neuropsychopharmacol. 2016 Apr;26(4):663-73. doi: 10.1016/j.euroneuro.2016.02.008. Epub 2016 Feb 20. Review.</citation>
    <PMID>26944296</PMID>
  </reference>
  <reference>
    <citation>Shih PB, Yang J, Morisseau C, German JB, Zeeland AA, Armando AM, Quehenberger O, Bergen AW, Magistretti P, Berrettini W, Halmi KA, Schork N, Hammock BD, Kaye W. Dysregulation of soluble epoxide hydrolase and lipidomic profiles in anorexia nervosa. Mol Psychiatry. 2016 Apr;21(4):537-46. doi: 10.1038/mp.2015.26. Epub 2015 Mar 31.</citation>
    <PMID>25824304</PMID>
  </reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 3, 2017</study_first_submitted>
  <study_first_submitted_qc>March 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2017</study_first_posted>
  <last_update_submitted>April 8, 2017</last_update_submitted>
  <last_update_submitted_qc>April 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Pei-an (Betty) Shih</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>psychopathology</keyword>
  <keyword>treatment</keyword>
  <keyword>epoxide hydrolases</keyword>
  <keyword>polyunsaturated fatty acids</keyword>
  <keyword>eicosanoids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

